Lilly Q3 Results Miss Estimates; Cuts FY16 EPS View, Backs Adj. EPS Forecast

Drug maker Eli Lilly and Co. reported Tuesday lower profit in its third quarter, despite higher revenues. Adjusted earnings per share and top line missed analysts' estimates. Further, for fiscal 2016, the company trimmed its forecast for reported earnings, while maintained adjusted earnings view, and raised revenue forecast.

from RTT - Earnings http://ift.tt/2eMZ9OT
via IFTTT